AZZAD Asset Management Inc. has filed its quarterly holdings report, revealing a total value of over $1.1 billion as of September 30, 2026. This filing is significant as it provides insights into the company's investment strategies and positions within the competitive asset management industry.

AZZAD Asset Management Inc. is a firm engaged in investment management. The company is registered with the SEC and operates under the Central Index Key (CIK) number 0001121914. The firm is based in Falls Church, Virginia and has been filing various reports, including the recent 13F-HR on November 4, 2026. This report is part of a series of filings, with the previous report dated July 29, 2026.

The latest filing indicates that AZZAD Asset Management holds investments in a diverse array of companies, totaling 341 entries. The total value of these holdings is reported at $1,114,629,128. The filing was signed by Kendra Means, a consultant at the firm, and was submitted under the SEC Act of 1934.

The report includes notable holdings in companies such as Abbott Laboratories, AbbVie Inc., and Alphabet Inc. These investments reflect AZZAD's strategy to diversify its portfolio across various sectors, including healthcare and technology. The firm has shown a commitment to maintaining a robust investment strategy, which may influence its competitors in the asset management space.

As the asset management industry continues to evolve, AZZAD's latest filings may serve as a benchmark for other firms in the sector. The insights drawn from this report could inform investment strategies across the industry, as firms analyze the performance and trends indicated by AZZAD's holdings.

Moving forward, it remains to be seen how AZZAD Asset Management will adjust its strategies in response to market conditions and the performance of its holdings. The filing does not specify what actions may follow this report, leaving industry observers to speculate on the company's next moves.